Adler Eric 4
4 · Lexeo Therapeutics, Inc. · Filed Feb 6, 2024
Insider Transaction Report
Form 4
Adler Eric
Chief Medical Officer
Transactions
- Award
Common Stock
2024-02-02+26,875→ 26,875 total - Award
Employee Stock Option (right to buy)
2024-02-02+161,250→ 161,250 totalExercise: $17.00Exp: 2034-02-01→ Common Stock (161,250 underlying)
Footnotes (2)
- [F1]The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]25% of the shares underlying the option vest and become exercisable on February 2, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.